Fda

(Image: Getty/gorodenkoff)

Avalere: FDA can impact COVID-era drug development

By Jenni Spinner

A representative of the life-sciences consulting firm outlines how the federal agency has reacted to the COVID-19 pandemic, and how it might advise the industry going forward.

(Image: Getty/zubada)

This week's FDA COVID-19 actions and advice

By Jenni Spinner

The federal agency continues to offer advice for healthcare and pharma industry professionals, and to take action against companies acting out of bounds.

(Image: Getty/ffrikretow)

Weekly FDA COVID-19 update

By Jenni Spinner

The agency continues to remain busy overseeing and approving potential treatments and tests for the virus behind the global pandemic.

(Image: Getty/zubada)

This week’s FDA COVID-19 news

By Jenni Spinner

The agency continues to offer guidance about COVID-19 treatments and tests—and issue warnings to companies that fall out of line.

(Image: Getty/css0101)

FDA update on COVID-19 actions and advisements

By Jenni Spinner

Over the past week, the agency has issued guidances, taken action to accelerate treatments and put a stop to fraudulent treatments for the pandemic-causing virus.

(Image: Getty/ffikretow)

FDA COVID-19 response roundup

By Jenni Spinner

The federal agency continues to take action and make announcements centered on nationwide efforts to combat the virus causing the global pandemic.

(Image: Getty/Rafael Abdrakhmanov)

FDA updates and actions on COVID-19

By Jenni Spinner

The federal agency has announced a slew of legislation, advisory statements and other items impacting the US in the face of the pandemic.

(Image: Getty/Evgenii Kovalev)

FDA roundup of COVID-19 responses

By Jenni Spinner

The federal agency has been busy in recent weeks, taking actions and issuing advice in the face of the global coronavirus pandemic.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers